<DOC>
	<DOC>NCT00622427</DOC>
	<brief_summary>Primary: We hypothesize a clinically significant improvement in sleep latency, sleep-onset and total sleep time measures in adults with ADHD when given a trial of Ramelteon compared to placebo. Secondary:We expect that Ramelteon will show statistically significant improvements vs. placebo in measures of daytime sleepiness and with no decrement in daytime functioning, including such specific items as focus and social and occupational functioning.</brief_summary>
	<brief_title>Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia</brief_title>
	<detailed_description>Method: 8-week, randomized, double-blind, placebo-controlled crossover trial of Ramelteon in adult ADHD subjects who suffer from initial insomnia.</detailed_description>
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<criteria>Diagnosis of ADHD and insomnia 1965 years of age In good general health Negative pregnancy test Current primary psychiatric diagnosis other than ADHD Positive urine drug screen for any sedative hypnotic or drugs of abuse Unstable medical condition HIV positive Seizure disorder Known hypersensitivity to Ramelteon</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>